Healthy Lifestyle Combined With GLP-1 RA Use Lowers Cardiovascular Risk in Patients With Type 2 Diabetes
Findings to be presented at the American Heart Association Scientific Sessions 2025 in New Orleans suggest that combining healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) therapy can significantly lower cardiovascular risk in patients with type 2 diabetes (T2D). The data, presented in Abstract Poster MP511, highlight the additive benefits of lifestyle modification and…